• 1
    Stohr K. Influenza–WHO cares. Lancet Infect Dis 2002; 2:517.
  • 2
    Rasmussen SA, Jamieson DJ, Uyeki TM. Effects of influenza on pregnant women and infants. Am J Obstet Gynecol 2012; 207(Suppl 3):S3S8.
  • 3
    Dawood FS, Iuliano AD, Reed C et al. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect Dis 2012; 12:687695.
  • 4
    Garten RJ, Davis CT, Russell CA et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009; 325:197201.
  • 5
    Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, Zambon M et al. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet 2010; 375:11001108.
  • 6
    Verma N, Dimitrova M, Carter DM et al. Influenza virus H1N1pdm09 infections in the young and old: evidence of greater antibody diversity and affinity for the hemagglutinin globular head domain (HA1 Domain) in the elderly than in young adults and children. J Virol 2012; 86:55155522.
  • 7
    Writing Committee of the W.H.O.C.o.C.A.o.P.I., Bautista E, Chotpitayasunondh T et al. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 2010; 362:17081719.
  • 8
    Neuzil KM, Reed GW, Mitchel EF, Simonsen L, Griffin MR. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol 1998; 148:10941102.
  • 9
    Iskander M, Booy R, Lambert S. The burden of influenza in children. Curr Opin Infect Dis 2007; 20:259263.
  • 10
    Poehling KA, Edwards KM, Weinberg GA et al. The underrecognized burden of influenza in young children. N Engl J Med 2006; 355:3140.
  • 11
    Jamieson DJ, Honein MA, Rasmussen SA et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 2009; 374:451458.
  • 12
    Siston AM, Rasmussen SA, Honein MA et al. Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA 2010; 303:15171525.
  • 13
    Fiore AE, Fry A, Shay D et al. Antiviral agents for the treatment and chemoprophylaxis of influenza — recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011; 60:124.
  • 14
    Grizas AP, Camenga D, Vazquez M. Cocooning: a concept to protect young children from infectious diseases. Curr Opin Pediatr 2012; 24:9297.
  • 15
    Glezen WP. Effect of maternal antibodies on the infant immune response. Vaccine 2003; 21:33893392.
  • 16
    Albrecht P, Ennis FA, Saltzman EJ, Krugman S. Persistence of maternal antibody in infants beyond 12 months: mechanism of measles vaccine failure. J Pediatr 1977; 91:715718.
  • 17
    Dagan R, Amir J, Mijalovsky A et al. Immunization against hepatitis A in the first year of life: priming despite the presence of maternal antibody. Pediatr Infect Dis J 2000; 19:10451052.
  • 18
    Gans HA. The status of live viral vaccination in early life. Vaccine 2012; 31:25312537.
  • 19
    Herlocher ML, Elias S, Truscon R et al. Ferrets as a transmission model for influenza: sequence changes in HA1 of type A (H3N2) virus. J Infect Dis 2001; 184:542546.
  • 20
    Maines TR, Belser JA, Gustin KM et al. Local innate immune responses and influenza virus transmission and virulence in ferrets. J Infect Dis 2012; 205:474485.
  • 21
    Jourdain E, Gunnarsson G, Wahlgren J et al. Influenza virus in a natural host, the mallard: experimental infection data. PLoS ONE 2010; 5:e8935.
  • 22
    Hamelin ME, Baz M, Abed Y et al. Oseltamivir-resistant pandemic A/H1N1 virus is as virulent as its wild-type counterpart in mice and ferrets. PLoS Pathog 2010; 6:e1001015.
  • 23
    Lakdawala SS, Lamirande EW, Suguitan AL Jr et al. Eurasian-origin gene segments contribute to the transmissibility, aerosol release, and morphology of the 2009 pandemic H1N1 influenza virus. PLoS Pathog 2011; 7:e1002443.
  • 24
    Reed LJ, Muench H. A simple method of estimating fifty percent endpoints. Am J Hyg 1938; 27:493497.
  • 25
    Chen Z, Wang W, Zhou H et al. Generation of live attenuated novel influenza virus A/California/7/09 (H1N1) vaccines with high yield in embryonated chicken eggs. J Virol 2010; 84:4451.
  • 26
    Maines TR, Jayaraman A, Belser JA et al. Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice. Science 2009; 325:484487.
  • 27
    Itoh Y, Shinya K, Kiso M et al. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 2009; 460:10211025.
  • 28
    Munster VJ, de Wit E, van den Brand JM et al. Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets. Science 2009; 325:481483.
  • 29
    Robertson JS, Nicolson C, Harvey R et al. The development of vaccine viruses against pandemic A(H1N1) influenza. Vaccine 2011; 29:18361843.
  • 30
    Wang W Lu J, Cotter CR, Wen K, Jin H, Chen Z. Identification of critical residues in the hemagglutinin and neuraminidase of influenza virus H1N1pdm for vaccine virus replication in embryonated chicken eggs. J Virol 2013; 87:46424649.
  • 31
    Huang SS, Banner D, Fang Y et al. Comparative analyses of pandemic H1N1 and seasonal H1N1, H3N2, and influenza B infections depict distinct clinical pictures in ferrets. PLoS ONE 2011; 6:e27512.
  • 32
    Rowe T , Leon AJ, Crevar CJ, Carter DM. Modeling host responses in ferrets during A/California/07/2009 influenza infection. Virology 2010; 401:257265.
  • 33
    Xu Q, Wang W, Cheng X, Zengel J, Jin H. Influenza H1N1 A/Solomon Island/3/06 virus receptor binding specificity correlates with virus pathogenicity, antigenicity, and immunogenicity in ferrets. J Virol 2010; 84:49364945.
  • 34
    Husseini RH, Sweet C, Overton H, Smith H. Role of maternal immunity in the protection of newborn ferrets against infection with a virulent influenza virus. Immunology 1984; 52:389394.
  • 35
    Sweet C, Jakeman KJ, Smith H. Role of milk-derived IgG in passive maternal protection of neonatal ferrets against influenza. J Gen Virol 1987; 68(Pt 10):26812686.
  • 36
    Suffin SC, Prince GA, Muck KB, Porter DD. Immunoprophylaxis of respiratory syncytial virus infection in the infant ferret. J Immunol 1979; 123:1014.
  • 37
    Clements ML, Betts RF, Tierney EL, Murphy BR . Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus. J Clin Microbiol 1986; 24:157160.
  • 38
    Doherty PC, Kelso A. Toward a broadly protective influenza vaccine. J Clin Invest 2008; 118:32733275.
  • 39
    Abdelwhab EM, Grund C, Aly MM, Beer M, Harder TC, Hafez HM. Influence of maternal immunity on vaccine efficacy and susceptibility of one day old chicks against Egyptian highly pathogenic avian influenza H5N1. Vet Microbiol 2012; 155:1320.
  • 40
    van Maanen C, Bruin G, de Boer-Luijtze E, Smolders G, de Boer GF. Interference of maternal antibodies with the immune response of foals after vaccination against equine influenza. Vet Q 1992; 14:1317.
  • 41
    Vincent AL, Ma W, Lager KM et al. Live attenuated influenza vaccine provides superior protection from heterologous infection in pigs with maternal antibodies without inducing vaccine-associated enhanced respiratory disease. J Virol 2012; 86:1059710605.
  • 42
    Gans H, DeHovvitz R, Forghani B et al. Measles and mumps vaccination as a model to investigate the developing immune system: passive and active immunity during the first year of life. Vaccine 2003; 21:33983405.
  • 43
    Moon SS, Wang Y, Shane AL et al. Inhibitory effect of breast milk on infectivity of live oral rotavirus vaccines. Pediatr Infect Dis J 2010; 29:919923.